China

Index
Media OutReach

Media OutReach Newswire Launches Industry-First Press Release Distribution Campaign Intelligence Report

Globenewswire

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as the First-line Treatment of Extensive-stage Small Cell Lung Cancer

Media OutReach

As WWII Survivors Dwindle, Their Stories Live On: Exhibition on Jewish Refugees in Shanghai to Open in NYC

Globenewswire

Banle Energy Launches Its First Biofuel Bunkering Operation in Hong Kong

Media OutReach

Correcting and Replacing: Jardine Matheson and Hongkong Land celebrate 50 years of Jardine House

Media OutReach

China Business Knowledge White Paper Series: The Unstoppable Rise of Sustainable Investing

Media OutReach

Jardine Matheson and Hongkong Land Celebrate 50 Years of Jardine House: Hong Kong's First Skyscraper Continues to Innovate and Attract World-class Tenants

Globenewswire

Rediscovering History: Exploring the Fascinating the Ancient Tea-Horse Road in Yunnan

Globenewswire

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab

Media OutReach

Freshippo Officially Launches Largest Supply Chain Operations Center in Shanghai

Globenewswire

Yunnan Innyo and VisitYunnan Collaborate to Launch Tourism Videos Showcasing the Ancient Tea-Horse Road

Globenewswire

Flash News: OKX Partners with Pulsar to Boost Liquidity for Hong Kong Users

Globenewswire

Floship CEO Josh Tsui to Deliver Executive Vision Talk on Future of Logistics Technology & Accept Award at New York’s Lead Innovation Summit

Globenewswire

CEO Floship Josh Tsui akan Menyampaikan Pidato Visi Eksekutif tentang Masa Depan Teknologi Logistik & Menerima Penghargaan di Lead Innovation Summit di New York

Media OutReach

Alibaba Cloud Unveils AI Image Generation Model Tongyi Wanxiang to Help Businesses to Unleash Creativity and Productivity

Media OutReach

TUMI Luncurkan Essentially Beautiful Pop-Up yang Memikat di Seoul

Media OutReach

Coface Asia Corporate Payment Survey 2023: Asian Companies Experience Fewer Payment Felays and Are Rather Optimistic Despite Multiple Headwinds Ahead

Globenewswire

Junshi Biosciences Announces Initiation of Phase 3 Study of Tifcemalimab plus Toripalimab for Treatment of Limited-stage Small Cell Lung Cancer